Free Trial

VolitionRx (VNRX) Insider Trading & Ownership

VolitionRx logo
$0.66 +0.07 (+12.60%)
(As of 03:52 PM ET)

VolitionRx (NYSE:VNRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.80%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$313,011.62
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$18,000.00
Get VNRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling VolitionRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VNRX Insider Buying and Selling by Quarter

VolitionRx Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/9/2024Cameron John ReynoldsCEOBuy139,811$0.57$79,692.27  
12/9/2024Guy Archibald InnesDirectorBuy174,764$0.57$99,615.48  
12/9/2024Jacob Vincent MicallefInsiderBuy43,691$0.57$24,903.87  
8/20/2024Guy Archibald InnesDirectorBuy150,000$0.67$100,500.00  
1/2/2024Corp Ltd EightMajor ShareholderSell20,000$0.90$18,000.00  
12/18/2023Salvatore Thomas ButeraCEOBuy10,000$0.83$8,300.00  
(Data available from 1/1/2013 forward)

VNRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at VolitionRx includes Cameron John Reynolds, Corp Ltd Eight, Gaetan Michel, Guy Archibald Innes, Jacob Vincent Micallef, Martin Charles Faulkes, Phillip Barnes, Rodney Gerard Rootsaert, and Salvatore Thomas Butera. Learn more on insiders at VNRX.

12.80% of VolitionRx stock is owned by insiders. Learn more on VNRX's insider holdings.

The following insiders have purchased VNRX shares in the last 24 months: Cameron John Reynolds ($86,392.27), Gaetan Michel ($6,150.00), Guy Archibald Innes ($237,315.48), Jacob Vincent Micallef ($63,653.87), Martin Charles Faulkes ($12,436.48), Phillip Barnes ($6,500.00), Rodney Gerard Rootsaert ($6,000.00), and Salvatore Thomas Butera ($24,100.00).

Insiders have purchased a total of 659,232 VNRX shares in the last 24 months for a total of $442,548.10 bought.

The following insider sold VNRX shares in the last 24 months: Corp Ltd Eight ($33,000.00).

Insiders have sold a total of 40,000 VolitionRx shares in the last 24 months for a total of $33,000.00 sold.

VolitionRx Key Executives

  • Dr. Martin Charles Faulkes Ph.D. (Age 80)
    Executive Chairman
    Compensation: $239.51k
  • Mr. Cameron Reynolds MBA (Age 53)
    Founder, CEO, President & Director
    Compensation: $572.43k
  • Dr. Gaetan Michel Ph.D. (Age 50)
    Chief Operating Officer
    Compensation: $518.15k
  • Dr. Salvatore Thomas Butera DVM (Age 72)
    Chief Executive Officer of Volition Veterinary Diagnostics Development LLC
    Compensation: $477.25k
  • Mr. Terig Hughes (Age 53)
    CFO & Treasurer
    Compensation: $338.74k
  • Dr. Jacob Vincent Micallef MBA (Age 68)
    Ph.D., Chief Scientific Officer
    Compensation: $571.55k
    1 recent trades
  • Mr. Nicholas Plummer (Age 53)
    Group General Counsel
  • Ms. Louise Batchelor Day (Age 52)
    Group Chief Marketing & Communications Officer
  • Mr. Thomas Bygott
    Sales & Marketing Director
  • Mr. Gael Forterre M.B.A. (Age 42)
    Chief Commercial Officer


This page (NYSE:VNRX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners